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Apoptosis is a form of programmed cell death that is essential for the development and tissue homeostasis in all metazoan animals.
Mitochondria play a critical role during apoptosis, since the release of pro-apoptogenic proteins from the organelle is a pivotal event in cell death
triggered by many cytotoxic stimuli. A striking morphological change occurring during apoptosis is the disintegration of the semi-reticular
mitochondrial network into small punctiform organelles. It is only recently that this event has been shown to require the activity of proteins
involved in the physiological processes of mitochondrial fission and fusion. Here, we discuss how this mitochondrial morphological transition
occurs during cell death and the role that it may have in apoptosis.
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Apoptosis is a form of programmed cell death that is
essential for the development of the embryo and to maintain
tissue homeostasis in adult multicellular organisms. Disrupting
such a vital process leads to a range of diseases, such as cancer,
neurodegeneration and autoimmunity. Apoptosis is character-
ized by a stereotyped series of morphological changes including
membrane blebbing, cell shrinkage, chromatin condensation
and inter-nucleosomal DNA cleavage. This process culminates
in the formation of apoptotic bodies, plasma membrane vesicles
enclosing the digested cellular material, which are engulfed by
neighbouring cells and macrophages, thus preventing inflam-
mation [1,2]. This orderly destruction of the cell is orchestrated
by a family of cysteine proteases called caspases [3]. Given their
pre-eminent role in apoptosis, it is reasonable to suppose that
caspases are strictly controlled. Depending on the cell type and
death stimulus, two pathways are known to regulate caspases:
(1) the extrinsic pathway, which is initiated by the binding of a
death ligand to its death receptor resulting in the rapid activation
of caspases [4]; (2) the intrinsic pathway, whereby the death
stimulus activates a signalling cascade triggering mitochondrial⁎ Corresponding author. Tel.: +41 22 702 64 43; fax: +41 22 702 64 42.
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pro-apoptogenic factors into the cytosol [5,6]. Some of these
proteins are now known to contribute to the activation of
caspases either through the apoptosome (cytochrome c) or by
binding to IAPs (Inhibitors of Apoptosis Proteins; Smac/Diablo,
HtrA2/Omi) [7]. MOMP is a critical event in the intrinsic
apoptotic pathway and it is induced by a subclass of pro-
apoptotic Bcl-2 proteins which includes Bax and Bak [8]. These
proteins seem to be in an inactive state in healthy cells, with Bax
mostly found in the cytosol. However, during apoptosis induced
by various death stimuli, including DNA damage or trophic
factor deprivation, they are activated by a process requiring
BH3-only Bcl-2 family members [9,10]. It is thought that BH3-
only proteins bind and sequester Bcl-2 anti-apoptotic proteins
(this is the case for Bad and NOXA), or bind to and directly
activate pro-apoptotic proteins (tBid for example). This leads to
the inactivation of Bcl-2 anti-apoptotic proteins and the
oligomerisation/insertion of Bax and Bak in the MOM, which
results in MOMP.
The mechanisms underlying MOMP are still unclear and are
the subject of much debate [9,11]. A new twist to the story was
brought on by the rediscovery that mitochondria fragment
during cell death, an event that has recently been shown to
require proteins of the mitochondrial fission machinery [12].
The scope of this review is to summarise these findings and
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ical relevance of mitochondrial fission in apoptosis: (1) how is
fission activated during cell death? (2) What role does fission of
the mitochondria play in MOMP? (3) Is mitochondrial fission
required for cell death?
2. Mitochondria fragment during apoptosis
The mitochondria form a highly dynamic semi-tubular
network, the morphology of which is regulated by movements
along the cytoskeleton and frequent fission and fusion events.
Our understanding of the mechanisms underlying mitochondrial
fission and fusion mostly comes from studies in yeast.
Coincidentally, the molecular components implicated in both
these processes are highly conserved in other species such as
mammals, C. elegans and Drosophila [13,14]. For the purpose
of this review only a brief outline of the proteins involved in
mitochondrial fission and fusion in mammalian cells will be
given. At least four proteins, Drp1, hFis1, MTP18 [15,16] and
GDAP1 [17,18] are required for mitochondrial fission. The
dynamin-related protein Drp1 is a large cytosolic GTPase that
translocates to the mitochondria where it couples GTP
hydrolysis with scission of the mitochondrial tubule [19–21].
Its receptor at the surface of the mitochondria is thought to be
hFis1, which is anchored to the MOM facing the cytoplasm
[22–25]. Mitochondrial fusion in mammalian cells utilises a
different set of proteins: the large transmembrane GTPase
mitofusins (Mfn1, Mfn2) anchored on the MOM and the
dynamin-like GTPase OPA1 located in the mitochondrial
intermembrane space [13,14,26].
A striking event occurring during apoptosis is the disinte-
gration of the semi-reticular mitochondrial network into small
punctiform organelles. Initially, before mitochondria could be
observed in live cells, ultra-structural studies showed that in
apoptotic cells the mitochondria were structurally intact but
appeared to be condensed [27–31]. A reduction of the
mitochondrial volume had already been observed in patholog-
ical tissue, which were retrospectively found to undergo
apoptosis [32–35]. More recently, ultra-condensation or
fragmentation of mitochondria was observed in a range of cell
types undergoing apoptosis [36–38]. Interestingly, this change
in mitochondrial morphology is reversible in sympathetic
neurons upon re-addition of the trophic factor to the culture
medium [39]. Of note in addition to the mitochondria becoming
fragmented during apoptosis, the organelles, which are
normally evenly distributed in healthy cells, cluster around
the nucleus during cell death. This relocation of the mitochon-
dria has been attributed to the inactivation of mitochondria-
associated kinesin [40].
Since mitochondrial condensation or fragmentation has been
observed so consistently during apoptosis, this begs the
question as to what is the molecular mechanism regulating
this process. Frank and co-workers were the first to address this
question and hypothesized that components of the “classical”
mitochondrial fission machinery were involved in the fragmen-
tation of the mitochondria during apoptosis. The authors show
that Drp1 translocates to the mitochondria during Bax/Bak-dependent apoptosis and that inhibiting the activity of Drp1 (by
over-expression of the dominant negative mutant DrpK38A)
efficiently prevents fragmentation of the mitochondria [12].
These results were supported by a more recent study from the
same laboratory showing that down-regulating the expression
of hFis1 or Drp1 prevents fragmentation of the mitochondrial
network during Bax/Bak-dependent apoptosis. Drp1-dependent
fragmentation of the mitochondrial network has also been
observed in a different death paradigm. Work from Breck-
enridge and co-workers [41] implicated mitochondrial fission in
the fragmentation of the organelle during death induced by p20,
the product of BAP31 caspase cleavage during Fas mediated
death. In this study the authors show that the increase in
cytosolic calcium triggered by p20 expression is required for
mitochondrial fragmentation, which occurs after the recruitment
of Drp1 to the organelle, and that disintegration of the
mitochondrial network is inhibited by the expression
DrpK38A [41]. In an effort to further elucidate the molecular
mechanisms regulating the fragmentation of the mitochondrial
network during apoptosis, Sugioka and colleagues [47]
inhibited this event by activating the mitochondrial fusion
machinery. The authors show that over-expression of rat Fzo1A,
B (homologues of the human mitofusins) in HeLa cells prevents
the fragmentation of the mitochondrial network during Bax/
Bak-dependent cell death, thus suggesting that mitochondrial
fusion might be affected during apoptosis. This is in agreement
with work from Karbowski and co-workers [42,45] who used a
mitochondrially targeted photoactivable green fluorescent
protein to assess the rates of mitochondrial fusion during
apoptosis. The authors show that the diffusion rate of the probe
after photoactivation is significantly decreased in cells under-
going apoptosis, thus suggesting that mitochondrial fusion is
inhibited during cell death [42].
Altogether these studies show that mitochondrial fragmen-
tation occurring during apoptosis is mediated by an increase in
the fission of the organelle, following the recruitment of Drp1,
and an inhibition of fusion. How are these two events regulated
during apoptosis? It has been proposed that Bax plays a critical
role in this control. This is based on the finding that Bax co-
localizes with Drp1 and Mfn2 in distinct foci, possibly future
scission sites, on the mitochondria after the induction of
apoptosis [43,44]. Furthermore, endophilin B1, a protein
required for the maintenance of the mitochondrial morphology
and that translocates to the mitochondria during cell death [45],
has been shown to interact with Bax only after the induction of
apoptosis [46]. These results would suggest that Bax regulates
the morphological changes of the mitochondria during
apoptosis through its interaction with components of the
mitochondrial fission and fusion machinery. However, there is
no evidence in the literature supporting the existence of a direct
interaction between Bax and Drp1 or Mfn2. Nevertheless, such
interactions might exist but may be transient and difficult to
detect. A second concern about this model is that Bcl-2, a well-
established inhibitor of Bax, does not prevent mitochondrial
fission [47]. Furthermore, Drp1 is equally recruited to
mitochondria during apoptosis in cells lacking Bax and Bak
[47]. However, we cannot exclude that Bcl-2 is not able to
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morphological changes and that Drp1 translocation does not
depend on Bax/Bak. Interestingly, over-expression of tBid
(corresponding to the caspase cleaved active form of Bid), a
known activator of Bax [48], does not lead to recruitment of
Drp1 or fragmentation of the mitochondrial network during
apoptosis [47]. Attention should also be drawn to the fact that
the co-localization of Bax with Mfn2 in distinct foci is in
disagreement with previous studies showing that Mfn2
distributes evenly on the mitochondria without forming visible
foci [49–52]. However, it remains possible that Mfn2
aggregates in distinct regions of the mitochondria only after
the induction of apoptosis, although this has not been shown
yet. Finally, it is unlikely that Bax activates the mitochondrial
fission machinery after ER calcium release following p20 over-
expression, since in this case mitochondrial fragmentation
precedes the activation of Bax and the release of cytochrome c
[41].
Recent evidence has been published that provides an
alternative mechanism to explain how mitochondrial fission is
activated and fusion is inhibited during cell death. Detailed
kinetic studies have revealed that mitochondria fragment afterFig. 1. Model mechanisms for the activation of mitochondrial fission during cell de
trigger the translocation of Bax, Drp1 and Endophilin B1 to the mitochondria. Active
and also inhibits fusion of the organelle through its interaction with Mfn2. Remodell
linked to the activation of fission or inhibition of fusion. Activated Bax forms pores a
trigger the translocation of Bax to the mitochondria. Active Bax forms oligomers
mitochondria, such as Smac/DIABLO, DDP/TIMM8a and some cytochrome c. Once
mitochondria. This event is followed by Drp1-dependent fission, release of OPA1, re
the remaining cytochrome c. (C) Pro-apoptotic signals triggering the release of E
mitochondria and fission of the organelle. Remodeling of the intra-mitochondrial spa
in mitochondrial calcium. This is followed by the translocation of Bax and the formati
the mitochondria.the release of cytochrome c in mammalian cells and in
trypanosoma [53–55]. Incidentally, Arnoult and co-workers
find that OPA1 and DDP/TIMM8a are both released from the
mitochondria after MOMP during Bax/Bak-dependent cell
death [53,56]. The release of OPA1 could potentially explain the
inhibition of mitochondrial fusion occurring during apoptosis,
since mitochondria in OPA1 depleted cells are heavily
fragmented [57–59]. Concerning DDP/TIMM8a, the authors
show that it binds to Drp1 and promotes its recruitment to the
mitochondria, thus providing a mechanism for how mitochon-
drial fission is activated during apoptosis. Nevertheless, this
model does not explain why Bcl-2 over-expression is unable to
prevent mitochondrial fragmentation during Bax/Bak-depen-
dent cell death [47]. Of note, the data from Arnoult and co-
workers does not exclude that in other death paradigms, such as
in death receptor activated apoptosis, mitochondrial fragmen-
tation might occur prior to the activation of Bax and cytochrome
c release, as shown by Breckenridge and colleagues [41].
In summary, mitochondrial fragmentation occurs in most
forms of apoptosis and is due to activation of mitochondrial
fission machinery as well as the inhibition of fusion. However,
how this process is regulated is still unclear (see Fig. 1).ath and for the role of fission in MOMP. (A) Bax/Bak-dependent death stimuli
Bax participates in the activation of Drp1-dependent fission of the mitochondria
ing of the inner mitochondrial space occurs by an unknown mechanism possibly
cross the MOM that contribute to MOMP. (B) Bax/Bak-dependent death stimuli
that allow the release of proteins soluble in the inter membrane space of the
in the cytosol, DDP/TIMM8a binds to Drp1 and promotes its translocation to the
modeling of the intramitochondrial space due to the loss of OPA1 and release of
R calcium, such as p20 over-expression, lead to translocation of Drp1 to the
ce occurs through a Drp1-dependent mechanism and possibly also due to the rise
on of Bax containing pores that trigger the release of pro-apoptotic proteins from
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It is now becoming accepted that mitochondrial fragmenta-
tion is an integral part of most forms of apoptosis. However, the
role of this change in mitochondrial morphology during cell
death is still unclear. As mentioned above, disintegration of the
mitochondrial network occurs within the same time frame as
Bax activation and MOMP in most cases studied. Although the
precise mechanisms of MOMP are still debated, it is accepted
that Bax and Bak are essential for this process [60]. One model,
based on the structural similarity of Bax/Bak to certain pore
forming bacterial toxins, suggests that these pro-apoptotic Bcl-2
proteins form large channels that permeabilise the MOM
[61,62]. An alternative model proposes that MOMP occurs
following the formation of a large conductance channel
containing Bax and components of the permeability transition
pore (PTP), such as the voltage-dependent anion-selective
channel (VDAC; [63]) and the adenine nucleotide translocator
(ANT; [64]). Does mitochondrial fission play a role in MOMP?
Several studies have reported that preventing mitochondrial
fission during apoptosis leads to a partial inhibition of
cytochrome c release [12,41,44,47,59]. This suggests that
mitochondrial fragmentation or components of the mitochon-
drial fission/fusion machinery could be involved in one of the
events leading to MOMP, such as the translocation and/or the
activation of Bax/Bak at the MOM. The translocation of Bax
and its activation at the mitochondria have been shown to occur
normally in cells depleted of Drp1 or transfected with DrpK38A
[12,43,59,65]. This is in disagreement with results obtained by
Neuspiel and co-workers [44] who show that the amount of
conformationally active Bax at the mitochondria is significantly
reduced in DrpK38A transfected cells [44]. Furthermore, over-
expression of rat Fzo1A,B also delays the translocation of Bax
to the mitochondria and the oligomerisation of Bax and Bak at
the MOM [47]. Nevertheless, preventing mitochondrial fission
during apoptosis by depleting cells of hFis1 instead of Drp1
does prevent Bax translocation and activation at the mitochon-
dria [59]. Altogether, it is still not completely clear if and how
preventing mitochondrial fragmentation during cell death
affects the translocation of Bax and the activation of Bax/Bak
at the MOM. It is possible that different components of the
mitochondrial fission/fusion machinery are required at distinct
steps of the activation of Bax/Bak. The fused morphology of the
mitochondria in hFis1-depleted cells or in cells over-expressing
Fzo1A,B might hamper the insertion of Bax/Bak in the MOM.
This would be consistent with previous data showing that
membrane curvature influences the permeabilisation of lipo-
somes by Bax [66,67]. However, inhibiting the function of Drp1
also leads to fusion of the mitochondrial network and according
to several studies activation of Bax is not inhibited in these cells.
As mentioned previously, Bax has been shown to form clusters
at scission sites together with Drp1 and Mfn2, possibly
implying that either of these two proteins could be involved
in the activation or the targeting of Bax to the mitochondria.
Nevertheless, in addition to the concerns raised above regarding
this hypothesis, it has been proposed that the appearance of theBax, Drp1, Mfn2 containing clusters follows cytochrome c
release and thus might be subsequent to an initial activation of
Bax [53]. Yet this does not exclude that components of the
fission/fusion machinery or the fragmentation of mitochondria
per se, might be required to further recruit and/or activate Bax/
Bak after an initial permeabilisation of the MOM. In this
scenario, fragmentation of the mitochondria during apoptosis
could be a positive feedback mechanism to amplify MOMP.
Nevertheless, mitochondrial fragmentation is not always
required for MOMP. Very limited mitochondrial fragmentation
occurs in mouse embryonic fibroblasts during etoposide
induced cell death and no mitochondrial fission was observed
when cell death was induced by tBid over-expression [47].
Furthermore, MOMP has been shown to occur in the
extensively fused mitochondria of MTP18 depleted cells [15].
Finally, cytochrome c release has been shown to occur with the
same kinetics at 37 °C or 24 °C. This, therefore, excludes the
involvement of the GTPase enzymatic activity of Drp1, or other
GTPases involved in mitochondrial fission and fusion, in the
release of cytochrome c.
Until recently, it was thought that MOMP was sufficient for
the complete release of cytochrome c. However, two pools of
cytochrome c exist within the mitochondria: a minor pool that is
soluble in the intermembrane space (IMS) and a major pool
confined to the mitochondrial cisternae [68–70]. Furthermore,
electron microscopic tomography of mitochondria revealed that
the IMS is separated from the intra-cisternal space by narrow
cristae junctions [71]. Therefore, to account for the complete
and fast release of cytochrome c during apoptosis [72], cisternal
cytochrome c must be relocated into the IMS before it can be
released through the Bax/Bak containing pore in the MOM.
Recently, it has been shown that several apoptotic stimuli cause
disruption of cristae junctions, resulting in opening of the cristae
and in the expansion of the intermembrane space [68,73,74]. In
particular, Scorrano and co-workers [68] showed that tBid not
only activates Bax/Bak to permeabilise the MOM but also
independently mediates a remodeling of the mitochondrial
cristae which is required for the complete release of cytochrome
c from the mitochondria. This intra-mitochondrial remodeling,
specified as Class II by the authors, is characterized by a
network of fused cristae with widened inter-cristae junctions.
What is the role of mitochondrial fission and fusion in the intra-
mitochondrial rearrangements occurring during apoptosis? The
molecular mechanisms regulating cristae morphology and
architecture are still unclear. Nevertheless, mitochondrial
proteins required to maintain normal mitochondrial shape
have been implicated in this process by recent studies. The
yeast MIM protein Mdm33 and the MOM protein Mmm1p have
been shown to play an important role in intra-mitochondrial
organization [75,76]. In mammalian cells, mitofilin, an IMS
protein, is required for proper formation of MIM cristae [77].
Nevertheless, the intra-mitochondrial rearrangements occurring
following the inactivation of the proteins listed above are not
similar to those in the Class II mitochondria described by
Scorrano and colleagues [68]. In contrast, the cristae morphol-
ogy of mitochondria from OPA1 depleted cells is highly
reminiscent of that in Class II mitochondria [53,57,58].
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tizes mammalian cells to apoptosis [58,59] and mitochondria
isolated from these cells release cytochrome cmore readily [53].
Finally, as mentioned above, OPA1 is released into the cytosol
during apoptosis induced by Bax/Bak-dependent death stimuli
[53]. These results suggest that OPA1 is likely to play an
important role in the remodeling of the intra-mitochondrial
space during apoptosis.
Drp1 has also been proposed to regulate intra-mitochondrial
rearrangements during apoptosis. This is based on the finding
that dominant negative DrpK38E inhibits remodeling of the
cristae following BIK induced apoptosis [65]. How Drp1, a
MOM protein, is involved in this process is still unclear. Other
dynamins, including dynamins 1 and 2, have previously been
reported to have activities independent of their role in
membrane fission due to, for example, their ability to bind
other proteins. One such protein is endophilin A1, which has
been shown to affect membrane curvature [78,79]. Interestingly,
endophilin B1 is a homologue of this protein [80,81]. Whether
Drp1 recruits or synergizes with endophilin B1 to remodel the
MOM and the intra-mitochondrial space still remains to be
demonstrated. Alternatively, dynamins have also been shown to
modulate actin dynamics at the membrane [82,83] or initiate
intracellular signaling cascades [84,85], both of which could
potentially explain how Drp1 induces remodeling of the MIM.
In summary, certain studies suggest that proteins involved in
mitochondrial fission/fusion may be implicated in the release of
pro-apoptotic factors from the mitochondria (Fig. 1). However,
it is not yet clear if these proteins are absolutely required for this
process and what role they play in it. Nevertheless, in line with
the hypothesis presented above, namely that mitochondrial
fragmentation could act as a positive feedback mechanism to
amplify Bax/Bak activation, fission of the organelle during
apoptosis could be involved in the remodeling of the intra-
mitochondrial space and therefore amplify the release of
cytochrome c by liberating the protein from the cisternal pool.
4. Mitochondrial fission and cell death
The release of pro-apoptogenic proteins from the mitochon-
dria is a critical event in cell death mediated through the
intrinsic apoptotic pathway [11]. Since mitochondrial fragmen-
tation may be involved in this process, is it sufficient to inhibit
mitochondrial fission in order to prevent cell death? To this date
a number of studies have addressed this question. Inhibiting
mitochondrial fission by over-expressing DrpK38A has been
suggested to inhibit apoptosis [12]. However, this result should
be interpreted cautiously. In fact, the authors compared the rate
of apoptosis of DrpK38A cells to that of DrpWT transfectants,
and it has been shown since that over-expression of DrpWT
sensitizes cells to death induced by staurosporine for example
[43,86]. This suggests that the protection that over-expression
of DrpK38A confers to cells might have been overestimated in
the Frank et al. study [12]. Consistently, depleting cells of Drp1
only confers mild protection against cell death induced by a
range of cytotoxic stimuli [59]. However, in the same study, the
authors find that depleting cells of hFis1 has a strong anti-apoptotic effect under the same conditions [59]. Although from
these studies, it is difficult to conclude that preventing
mitochondrial fission inhibits cell death, since apoptosis was
assessed at single time points, it cannot be excluded that
depleting cells of Drp1 or hFis1 delays the progression of
apoptosis. In agreement with this suggestion, Drp1 depletion or
Fzo1A,B over-expression delays death induced by a number of
apoptotic stimuli as assessed in time course experiments [47].
Whereas apoptosis induced by cytotoxic stimuli, such as
staurosporine or etoposide, is delayed when mitochondrial
fission is inhibited, calcium mediated cell death is partially
prevented when mitochondrial fragmentation is enhanced by
the over-expression of DrpWT [86]. This result does not concur
with data showing that DrpK38A partially inhibits cytochrome
c release and caspase 3 activation following release of ER
calcium induced by over-expression of p20 [41].
An alternative role for mitochondrial fission during
programmed cell death (PCD) has recently been proposed.
Studies have shown that mitochondria are eliminated during
PCD through a caspase-independent process known as
mitoptosis [87–89]. Arnoult and co-workers now provide
evidence that Drp1 mediated fission of the mitochondrial
network promotes the elimination of the mitochondria during
cell death, whereas expressing DrpK38A retards the disappear-
ance of the organelle [56]. These results suggest that
mitochondrial fission might play an active role in an alternative
form of PCD known as autophagic cell death [90,91].
Inducing mitochondrial fragmentation by over-expression of
hFis1 or down-regulation of OPA1 has been shown to cause the
release of cytochrome c and cell death in the absence of
apoptotic stimuli [25,58]. Excessive mitochondrial fragmenta-
tion induced by the over-expression of DrpWT in C. elegans has
also been shown to induce cell death [92]. These results have
often been used as evidence to suggest that mitochondrial
fission is required for cell death. However, this is probably an
over ambitious conclusion since there are many examples of
enhanced mitochondrial fission, or impaired mitochondrial
fusion, that do not result in cell death. Mammalian cells treated
with protonophores, which dissipate the MIM potential thus
inhibiting fusion, display heavily fragmented mitochondria but
remain viable for up to 24 h and their mitochondria retain
cytochrome c [93–95]. Healthy embryonic fibroblasts from
knockout mice lacking Mfn1 or Mfn2 can survive despite
having profoundly fragmented mitochondria [50]. A range of
cell types in which the expression of Fzo1A,B was down-
regulated do not die in the absence of additional apoptotic
stimuli [47]. The anti-apoptotic factor vMIA encoded by
cytomegalovirus induces mitochondrial fragmentation but
inhibits cytochrome c release and cell death [96]. Finally,
over-expression of DrpWT leads to fission of the mitochondrial
network without inducing cell death; on the contrary these cells
are protected against apoptosis induced by ceramide [86]. In
view of the results presented here, it would be more cautious to
suggest that apoptosis induced in certain cases of excessive
fission could be due to signals other than those regulating
mitochondrial fragmentation. Alternatively, it is possible that
mitochondria from OPA1 or hFis1 depleted cells are damaged
527P.A. Parone, J.-C. Martinou / Biochimica et Biophysica Acta 1763 (2006) 522–530and that this is the cause of death. In support of this
hypothesis, mitochondrial dysfunction has previously been
shown to trigger apoptosis [97–100]. Furthermore, OPA1
depleted cells have severely decreased cellular respiration
[101]. Finally, in patients with OPA1 mutations, suffering from
autosomal-dominant optic atrophy (ADOA), the copy number
of mitochondrial DNA (mtDNA) molecules is lower and
oxidative phosphorylation is decreased in the calf muscle of
these patients [102,103].
The role of mitochondrial fission in apoptosis has also been
studied in eukaryotes other than mammals. Studies in yeast have
shown that treating the cells with acetic acid or H2O2 leads to
fragmentation of the mitochondrial network and programmed
cell death [104]. Deleting the Drp1 homologue in yeast (Dnm1)
protected as much as 30% of the cells against apoptosis.
Interestingly, however, Dnm1-deficiency protected from cell
death more efficiently than from mitochondrial fragmentation.
This suggests that the absence of Dnm1 in yeast might confer
protection against cell death also by mechanisms other than
those related to fission of the mitochondria. In contrast to the
results obtained in mammalian cells, deletion of Fis in yeast
sensitizes the cells to apoptosis and leads to an increase in cell
death of approximately 30% [104]. In C. elegans, Drp1-
dependent mitochondrial fragmentation is induced by the BH3-
only protein EGL-1 in cells undergoing PCD during develop-
ment [92]. However, when mitochondrial fission is blocked, by
the expression of DrpK40A, 90% of the cells destined to die
during development do undergo PCD as planned. Moreover,
ced-9(n1950gf) and ced-9(n2812lf) both blocked mitochondrial
fragmentation induced by EGL-1 or Drp1 but ced-9(n2812lf)
animals, contrary to ced-9(n1950gf) animals, are not viable as a
result of ectopic programmed cell death. This implies that even
when mitochondrial fission is inhibited, PCD still occurs during
development. These results suggest that mitochondrial fission is
not required for cell death. However, this does not exclude that
fragmentation of the mitochondrial network might potentiate
cell death, as suggested by the authors.
In summary, it is not yet clear if mitochondrial fragmentation
is required for apoptosis. However, it is possible that preventing
mitochondrial morphological changes might delay apoptosis
without inhibiting it. The delay could be attributed to the partial
inhibition of cytochrome c release in these cells. Nevertheless,
we cannot exclude that the tools we use to prevent
mitochondrial fission during apoptosis also lead to changes in
mitochondrial function, thus possibly affecting the rate of
apoptosis. Therefore, results obtained using such tools should
be interpreted more carefully, and all possible reasons should be
examined or at least considered.
5. Concluding remarks
Over the past few years, mitochondrial fission has been
shown to occur in a range of cell types after the induction of
apoptosis by different death stimuli. Certain studies would
suggest that pro-apoptotic Bcl-2 family members are involved
in activating mitochondrial fragmentation during apoptosis, but
the mechanism involved remains elusive. Moreover, severallines of evidence argue against the possibility that Bax or Bak
might activate changes in mitochondrial morphology during
cell death. Mitochondrial fission has been shown to occur
before and after MOMP, depending on the death stimuli.
Therefore, it is not yet clear if mitochondrial fragmentation is
absolutely required for the permeabilisation of the MOM.
Nevertheless, it might provide a positive feedback mechanism
to amplify the initial release of pro-apoptogenic proteins from
the mitochondria. This would explain why a number of studies
have found that preventing mitochondrial fission delays cell
death. However, this is probably a simplistic conclusion since
the effects that preventing mitochondrial fission has on the
function of the organelle and on cellular homeostasis have never
been considered. Yet, this does not exclude that mitochondrial
fission might be required for other forms of PCD.
Therefore, much remains to be done to further elucidate the
true role of mitochondrial fission in apoptosis. Critical questions
still need to be answered. In particular, how is physiological
fission, which occurs frequently in healthy cells, different from
fragmentation of the mitochondrial network occurring during
apoptosis? Are pro-apoptotic Bcl-2 proteins implicated in
activating mitochondrial fragmentation during apoptosis and
what is the mechanism involved? How critical is the
requirement for mitochondrial fission in the release of pro-
apoptogenic proteins from the mitochondria and in cell death
progression? How much of the experimental evidence support-
ing a role of mitochondrial fission in apoptosis is due to
mitochondrial dysfunction resulting from the use of tools that
inhibit fission or activate fusion?
In view of the remarkable efforts that have been devoted to
elucidate the role of mitochondrial fragmentation in apoptosis, it
seems likely that these pending questions will soon be
answered. Luckily however, the field of mitochondrial
dynamics has a life after cell death and many fundamental
questions concerning the role of mitochondrial morphological
changes in cellular homeostasis and mitochondrial function still
remain unanswered. Addressing these questions is likely to
widen our understanding of the mitochondria in ways that go
beyond apoptosis.
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